Literature DB >> 2062987

Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels.

N Loimer1, R Schmid, J Grünberger, R Jagsch, L Linzmayer, O Presslich.   

Abstract

In methadone maintenance therapy methadone plasma concentrations of 400 ng/ml are necessary to suppress any further opiate action and to provide stabilized maintenance. In a controlled study we have searched for a differentiation in autonomous activation between patients having low and high methadone plasma levels, using static and dynamic pupillometry and habituation of skin conductance response. Results show that there is no difference in psychophysiological response between patients with high (greater than 400 ng/ml) or low (less than 400 ng/ml) plasma levels of methadone. This indicates that there is no reduction in behavioral arousal in patients with high plasma methadone levels. On the basis of these findings, there is no rationale to maintain patients on plasma levels below 400 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062987     DOI: 10.1007/bf02244255

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Inadequate plasma concentrations in some high-dose methadone maintenance patients.

Authors:  F S Tennant
Journal:  Am J Psychiatry       Date:  1987-10       Impact factor: 18.112

2.  Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenance treatment.

Authors:  M J Kreek
Journal:  N Y State J Med       Date:  1973-12-01

Review 3.  Drug interactions with methadone.

Authors:  M J Kreek; C L Gutjahr; J W Garfield; D V Bowen; F H Field
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

4.  Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome.

Authors:  S J Liu; R I Wang
Journal:  Am J Psychiatry       Date:  1984-10       Impact factor: 18.112

5.  Heroin addiction--a metabolic disease.

Authors:  V P Dole; M E Nyswander
Journal:  Arch Intern Med       Date:  1967-07

6.  The use of serum methadone levels in patients receiving methadone maintenance.

Authors:  J Bell; V Seres; P Bowron; J Lewis; R Batey
Journal:  Clin Pharmacol Ther       Date:  1988-06       Impact factor: 6.875

7.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

8.  Sustained attention in methadone patients.

Authors:  P W Appel
Journal:  Int J Addict       Date:  1982-12

Review 9.  Methadone treatment and acquired immunodeficiency syndrome.

Authors:  J R Cooper
Journal:  JAMA       Date:  1989 Sep 22-29       Impact factor: 56.272

10.  Effectiveness of low-dose methadone maintenance for the treatment of inner city heroin addicts.

Authors:  R J Craig
Journal:  Int J Addict       Date:  1980-07
View more
  8 in total

1.  Harm minimisation for drug misusers.

Authors:  C Brewer; J Marks; J Marks
Journal:  BMJ       Date:  1992-05-30

2.  Methadone deaths: a toxicological analysis.

Authors:  C M Milroy; A R Forrest
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

3.  Methadone treatment. Methadone concentrations taken as indicating deaths due to overdose need to be reviewed.

Authors:  J Merrill; T Garvey; C Rosson
Journal:  BMJ       Date:  1996-12-07

Review 4.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Pharmacogenetics of Methadone Response.

Authors:  Francina Fonseca; Marta Torrens
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

6.  Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice.

Authors:  Jun-Sheng Wang; Ying Ruan; Robin M Taylor; Jennifer L Donovan; John S Markowitz; C Lindsay DeVane
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

7.  Relationship between Serum Methadone Concentration and Cold Pressor Pain Sensitivity in Patients Undergoing Methadone Maintenance Therapy.

Authors:  Zalina Zahari; Chee Siong Lee; Muslih Abdulkarim Ibrahim; Nurfadhlina Musa; Mohd Azhar Mohd Yasin; Yeong Yeh Lee; Soo Choon Tan; Nasir Mohamad; Rusli Ismail
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

8.  In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis.

Authors:  Oscar A Linares; William E Schiesser; Jeffrey Fudin; Thien C Pham; Jeffrey J Bettinger; Roy O Mathew; Annemarie L Daly
Journal:  J Pain Res       Date:  2015-07-22       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.